Guardant Health raises 2025 revenue outlook to $915M–$925M amid strong Shield adoption and oncology momentum Guardant Health raises 2025 revenue outlook to $915M–$925M amid strong Shield adoption and oncology momentum Post ContentghRead More You might also be interested in reading Investors shrug off Trump’s 200% tariff threat on pharma. July 31, 2025 In Mainstream ← Previous post Next post →